(2024)
Organ-on-chip models for infectious disease research.
Nat Microbiol 9(4),
891-904.
Publikationen
(2024)
Alpha1-antitrypsin impacts innate host-pathogen interactions with Candida albicans by stimulating fungal filamentation.
Virulence 15(1),
2333367.
(2024)
Modeling of intravenous caspofungin administration using an intestine-on-chip reveals altered Candida albicans microcolonies and pathogenicity.
Biomaterials 307,
122525.
(2024)
A synthetic peptide mimic kills Candida albicans and synergistically prevents infection.
Nat Commun 15(1),
6818.
(2024)
Hyphal-associated protein expression is crucial for Candida albicans-induced eicosanoid biosynthesis in immune cells.
Eur J Immunol 54(3),
e2350743.
(2024)
Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis.
mBio 15(3),
e0340923.
(2023)
Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation.
Nat Immunol 24(2),
295-308.
(2023)
"Under Pressure" - How fungi evade, exploit, and modulate cells of the innate immune system.
Semin Immunol 66,
101738.
(Review)
(2023)
Th2-dependent STAT6-regulated genes in intestinal epithelial cells mediate larval trapping during secondary Heligmosomoides polygyrus bakeri infection.
PLoS Pathog 19(4),
e1011296.
(2022)
Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity.
Nat Commun 13(1),
3192.